Harrison.ai vs Qure.ai

A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.

Harrison.ai Australian-built AI for radiology and pathology — detecting 124+ findi... Visit Qure.ai FDA-cleared AI radiology platform detecting TB, stroke, lung cancer an... Visit
RECATOOLS Score 8.2 / 10 8.2 / 10
Capability 9 9
Value for money 7.5 7.5
Ease of use 7 7
ASEAN readiness 7.5 8.5
API quality 7 7
Pricing Enterprise Enterprise
Free tier Harrison.Rad 1.5 available free for research at chat.harrison.ai No free tier; enterprise contracts only; trial demos available via sales
Paid from Enterprise SaaS contracts; Open Platform charges for compute and support only Custom enterprise pricing; contact sales for per-scan or site-licence quotes
Has API
Open source
Free to use
Users 3,400+ clinicians at 1,000+ sites across 40+ countries 34M+ lives impacted across 4,800+ clinical sites in 105+ countries (as of late 2025)
Founded 2018 2016
Maker Harrison.ai (independent; Sonic Healthcare holds 18% stake via Franklin.ai JV) Independent (Series D — Lightspeed, 360 ONE Asset, Merck GHI Fund)
Verdict

Harrison.ai is one of the most clinically validated medical imaging AI platforms globally, backed by peer-reviewed publications in The Lancet Digital Health and European Radiology, 12 FDA clearances, three FDA Breakthrou...

Qure.ai is one of the most credentialled and widely deployed AI radiology platforms in the world, with a regulatory portfolio (26 FDA-cleared indications, Class IIb CE under EU MDR, CDSCO Class B in India, registrations...

Full review → Full review →
← Back to AI Directory

Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.